Il-35, an anti-inflammatory cytokine which expands CD4+CD25+ treg cells

Journal of Biological Regulators and Homeostatic Agents

Volumn 24, Issue 2, 2010, Pages 131-135

  Castellani, Maria Luisa ^a   Anogeianaki, A ^b   Felaco, P ^a   Toniato, E ^a   De Lutiis, M A ^a   Shaik, B ^c   Fulcheri, M ^a   Vecchiet, J ^a   Tete S ^a   Salini, V ^a   Theoharides, T C ^d   Caraffa, A ^e   Antinolfi, P ^e   Frydas, I ^b   Conti, P ^a   Cuccurullo, C ^a   Ciampoli, C ^a   Cerulli, G ^e   Kempuraj, D ^d  

^a UNIVERSITY OF CHIETI   (Italy)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Anti inflammatory cytokines; Autoimmunity; Interleukin 35; T cells; T helper cells

Indexed keywords

HETERODIMER; INTERLEUKIN 12P70; INTERLEUKIN 27; INTERLEUKIN 35; PROTEIN P35; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; CYTOKINE; INTERLEUKIN 12; INTERLEUKIN 35, HUMAN; INTERLEUKIN DERIVATIVE; INTERLEUKIN-35, HUMAN;

AUTOIMMUNITY; CD4+ CD25+ T LYMPHOCYTE; CELL EXPANSION; CELLULAR IMMUNITY; EFFECTOR CELL; EPSTEIN BARR VIRUS; GENE INDUCTION; HELPER CELL; HUMAN; INFLAMMATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; REGULATORY T LYMPHOCYTE; REVIEW; TH17 CELL; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL DIVISION; CYTOLOGY; DRUG EFFECT; EDITORIAL; IMMUNOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

HUMAN HERPESVIRUS 4;

CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL DIVISION; CYTOKINES; HUMANS; INFLAMMATION; INTERLEUKIN-12; INTERLEUKINS; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY;

EID: 77955857307     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Arend WP, Palmer G, Gabay C. IL-1, IL-18, and IL-33 families of cytokines. Immunol Rev 2008; 223: 20-38.
2. Chertov O, Yang D, Howard OM, Oppenheim JJ. Leukocyte granule proteins mobilize innate host defenses and adaptive immune responses. Immunol Rev 2000; 177:68-78.
3. Benucci M, Li Gobbi F, Sabadini L, Saviola G, Baiardi P, Manfredi M. The economic burden of biological therapy in rheumatoid arthritis in clinical practice: cost-effectiveness analysis of subcutaneous anti-TNFα treatment in Italian patients. Int J Immunopathol Pharmacol 2009; 22:1147-1152.
4. Palmqvist C, Wardlaw AJ, Bradding P. Chemokines and their receptors as potential targets for the treatment of asthma. Br J Pharmacol 2007; 151:725-36.
5. Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 2003; 21:217-229.
6. Luster AD. Chemokines-chemotactic cytokines that mediate inflammation. N Eng J Med 1998; 338:436-442.
7. Ciprandi G, De Amici M, Tosca MA, Pistorio A, Marseglia GL. Sublingual immunotherapy affects specific antibody and TGF-β serum levels in patients with allergic rhinitis. Int J Immunopathol Pharmacol 2009; 22:1089-1096.
8. Floudas CS, Yiakoumis X, Tsironi M, Aessopos A. Reversible normolipemic Xanthelasma palpebrarum associated with inflammation in Castleman's disease. Eur J Inflamm 2008; 6:95-8.
9. Li Q, Morimoto K, Kobayashi M, Inagaki H, et al. A forest bathing trip increases human natural killer activity and expression of anti-cancer proteins in female subjects. J Biol Regul Homeost Agents 2008; 22:45-55. (Pubitemid 351577892)
10. Aiello FB, Furian L, Marino S, Marchini F, Cardillo M, De Fazio N, Rigotti P, Valente M. Acute rejection features in dual kidney transplant recipients from elderly donors: comparison of calcineurin inhibitor-based and calcineurin inhibitor-free immunosuppressive protocols. Int J Immunopathol Pharmacol 2009; 22:1001-7.
11. Chen Q, Carroll HP, Gadina M. The newest interleukins: recent additions to the ever-growing cytokine family. Vitam Horm 2006; 74:207-28.
12. Inoue K, Takano H, Ohnuki M, Yanagisawa R, Sakurai M, Shimada A, Mizushima K, Yoshikawa T. Size effects of nanomaterials on lung inflammation and coagulatory disturbance. Int J Immunopathol Pharmacol 2008; 21:197-206.
13. Marzioni D, Lorenzi T, Mazzucchelli R, et al. Expression of basic fibroblast growth factor, its receptors and syndecans in bladder cancer. Int J Immunopathol Pharmacol 2009; 22:627-38.
14. Schillaci G, Rondelli F, Pirro M, Bagaglia F, Pucci G, Noya G, Mannarino E. Endothelial progenitor cells are mobilized after major laparotomic surgery in patients with cancer. Int J Immunopathol Pharmacol 2009; 22:1035-41.
15. Vojdani A, O'Bryan T, Kellermann GH. The immunology of gluten sensitivity beyond the intestinal tract. Eur J Inflamm 2008; 6:49-57.
16. Borrione P, Parisi A, Salvo RA, Spaccamiglio A, Pautasso M, Baraban D, Piccoli GB, Pigozzi F, Angeli A. A peculiar pattern of expression of the transferrin receptor (CD71) by reticulocytes in patients given recombinant human erythropoietin (rHuEPO): a novel marker for abuse in sport? J Biol Regul Homeost Agents 2007; 21:79-88.
17. Amedei A, Della Bella C, Niccolai E, Stanflin N, Benagiano M, Duranti R, Del Prete G, Murphy TF, D'Elios MM. Moraxella catarrhalis-specific TH1 cells in BAL fluids of chronic obstructive pulmonary disease patients. Int J Immunopathol Pharmacol 2009; 22:979-90.
18. Lavagno L, Ferrero E, Ortolan E, Malavasi F, Funaro A. CD157 is part of a supramolecular complex with CD11b/CD18 on the human neutrophil cell surface. J Biol Regul Homeost Agents 2007; 21:5-12.
19. Sessa R, Di Pietro M, Schiavoni G, et al. Chlamydia pneumoniae induces T cell apoptosis through glutathione redox imbalance and secretion of TNF-alpha. Int J Immunopathol Pharmacol 2009; 22:659-68.
20. Pistoia V, Cocco C, Airoldi I. Interleukin-12 receptor beta2: from cytokine receptor to gatekeeper gene in human B-cell malignancies. J Clin Oncol 2009; 27: 4809-16.
21. Tarantino G, Conca P, Tarantino M, Di Minno MND, Grimaldi E, Chianese D, Riccio A, Scopacasa F, Capone D. Does spleen volume play a role in patients with HCV-related chronic hepatitis? Int J Immunopathol Pharmacol 2009; 22:1009-1017.
22. Ciprandi G, Cirillo I, Pistorio A, Di Gioacchino M, Fenoglio D. Ebastine increases IFN-gamma production in patients with persistent allergic rhinitis. J Biol Regul Homeost Agents 2009; 23:31-6.
23. Zampetti A, Mastrofrancesco A, Flori E, Maresca V, Picardo M, Amerio P, Feliciani C. Proinflammatory cytokine production in HaCa T cells treated by eosin: implications for the topical treatment of psoriasis. Int J Immunopathol Pharmacol 2009; 22:1067-75
24. O'Garra A, Murphy KM. From IL-10 to IL-12: how pathogens and their products stimulate APCs to induce T(H)1 development. Nat Immunol 2009; 10: 929-32.
25. Riccio A, Postiglione L, Spanò A, Tarantino G. Lack of HCV replication during the course of HCV-associated arthritis. Eur J Inflamm 2008; 6:141-42.
26. Patruno A, Speranza L, Tetè S, et al. iNOS activity in the aged rat liver tissue J Biol Regul Homeost Agents 2007; 21:89-95.
27. Nishimura Y, Maeda M, Kumagai N, Hayashi H, Miura Y, Otsuki T. Decrease in phosphorylation of ERK following decreased expression of NK cell activating receptors in human NK cell line exposed to asbestos. Int J Immunopathol Pharmacol 2009; 22: 879-88.
28. Mennini T, Giordano L, Mengozzi M, et al. Increased IL-8 levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Eur J Inflamm 2009; 7: 39-44.
29. Collison LW, Vignali DA. Interleukin-35: odd one out or part of the family? Immunol Rev. 2008; 226: 248-62.
30. Ferrara G, Losi M, D'Amico R, et al. Interferon-gamma-release assays detect recent tuberculosis re-infection in elderly contacts. Int J Immunopathol Pharmacol 2009; 22:669-78.
31. Cantarini L, Lucherini OM, Cimaz R, et al. Idiopathic recurrent pericarditis refractory to colchicine treatment can reveal tumor necrosis factor receptor-associated periodic syndrome. Int J Immunopathol Pharmacol 2009; 22:1051-8.
32. Karapanou V, Kempuraj D, Theoharides TC. Oral neuroimmune network and mast cells. Eur J Inflamm 2009; 7:1-8.
33. Murdaca G, Colombo BM, Puppo F. Anti-TNF-alpha inhibitors: a new therapeutic approach for inflammatory immune-mediated diseases: an update upon efficacy and adverse events. Int J Immunopathol Pharmacol 2009; 22:557-65.
34. Collison LW, Workman CJ, Kuo TT, Boyd K, Wang Y, Vignali KM, Cross R, Sehy D, Blumberg RS, Vignali DA. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 2007; 450:566-9.
35. Colina M, Ciancio G, Garavini R, Conti M, Trotta F, Covoni M. Combination treatment with etanercept and an intensive spa rehabilitation program in active ankylosing spondylitis. Int J Immunopathol Pharmacol 2009; 22:1125-9.
36. Wilms H, Rosenstiel P, Romero-Ramos M, et al. Suppression of map kinases inhibits microglial activation and attenuates neuronal cell death induced by α-synuclein protofibrils. Int J Immunopathol Pharmacol 2009; 22:897-909.
37. Shuvy M, BenYa'acov A, Zolotarov L, Lotan C, Ilan Y. Beta glycosphingolipids suppress rank expression and inhibit natural killer T cell and CD8+ accumulation in alleviating aortic valve calcification. Int J Immunopathol Pharmacol 2009; 22:911-18.
38. Chiba Y, Sato S, Misawa M. GGTI-2133, an inhibitor of geranylgeranyltransferase, inhibits infiltration of inflammatory cells into airways in mouse experimental asthma. Int J Immunopathol Pharmacol 2009; 22:929-35.
39. Bardel E, Larousserie F, Charlot-Rabiega P, Coulomb-L'Herminé A, Devergne O. Human CD4+ CD25+ Foxp3+ regulatory T cells do not constitutively express IL-35. J Immunol. 2008; 181: 6898-905.
40. Bettini M, Vignali DA. Regulatory T cells and inhibitory cytokines in autoimmunity. Curr Opin Immunol 2009; 21:612-8.
41. Marasini B, Conciato L, Belloli L, Massarotti M. Systemic sclerosis and cancer. Int J Immunopathol Pharmacol 2009; 22:573-8.
42. Collison LW, Vignali DA. Interleukin-35: odd one out or part of the family? Immunol Rev 2008; 226: 248-62.
43. Allan SE, Song-Zhao GX, Abraham T, McMurchy AN, Levings MK. Inducible reprogramming of human T cells into Treg cells by a conditionally active form of FOXP3. Eur J Immunol 2008; 38: 3282-9.
44. Boissier MC, Assier E, Biton J, Denys A, Falgarone G, Bessis N. Regulatory T cells (Treg) in rheumatoid arthritis. Joint Bone Spine 2009; 76:10-4.
45. Meazza C, Travaglino P, Pagani S, Laarej K, Duse M, Bozzola M. Hyperimmunoglobulinaemia in babinga pygmies is present from infancy. Int J Immunopathol Pharmacol 2009; 22:1117-20.
46. Li Q, Kobayashi M, Wakayama Y, et al. Effect of phytoncide from trees on human natural killer cell function. Int J Immunopathol Pharmacol 2009; 22: 951-9.
47. Guida G, Culla B, Scirelli T, et al. Exhaled nitric oxide and nitric oxide synthase expression in Hodgkin's disease. Int J Immunopathol Pharmacol 2009; 22:1027-34.